Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005, 149(1):57-62 | DOI: 10.5507/bp.2005.005

DIFFERENTIATION OF TUMOURS OF DUCTAL AND LOBULAR ORIGIN: I. PROTEOMICS OF INVASIVE DUCTAL AND LOBULAR BREAST CARCINOMAS

Gulisa Turashvilia, Jan Bouchala, George Burkadzeb, Zdeněk Kolářa
a Laboratory of Molecular Pathology and Institute of Pathology, Palacky University, Hnevotinska 3, 77515 Olomouc, Czech Republic
b Department of Pathology, Tbilisi State Medical University, Asatiani 7, 0177 Tbilisi, Georgia

The vast majority of invasive breast tumors are ductal and lobular breast carcinomas. Despite the many similarities, some clinical follow-up data and the patterns of metastases suggest that these histological subtypes of breast cancer are biologically distinct. Few papers, however, describe immunohistochemical markers useful for differentiation of these carcinomas. Many investigations suggest that E cadherin protein expression is lost in lobular but not in ductal carcinoma. The absence of E-CD, as a partial loss of epithelial differentiation, may account for the extended spread of lobular carcinoma in situ and the peculiar diffuse invasion mode of invasive lobular carcinoma. Some investigations report the significance of E-CD associated proteins alpha-, beta-, gamma-catenin expression, as well as the usefulness of cytokeratins 5, 6, 8, 7 and thrombospondin in differentiating histological types of breast invasive carcinomas. Several reports have suggested the possibility that invasive ductal and lobular cancers differ with respect to expression of antigens involved in proliferation and cell cycle regulation. It has been shown that vascular endothelial growth factor expression, also the expression of maspin, a tumour suppressor gene product, is higher in ductal, than in lobular carcinoma. Expression of NKX3.1, a member of the NK-class of homeodomain, is highly restricted and is found primarily in lobular carcinoma. Some histological and immunohistochemical characteristics of pleomorphic lobular carcinoma are also discussed.

Keywords: Invasive ductal carcinoma, Invasive lobular carcinoma, Breast cancer, Immunohistochemistry, Differential

Received: April 20, 2005; Accepted: June 5, 2005; Published: July 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Turashvili, G., Bouchal, J., Burkadze, G., & Kolář, Z. (2005). DIFFERENTIATION OF TUMOURS OF DUCTAL AND LOBULAR ORIGIN: I. PROTEOMICS OF INVASIVE DUCTAL AND LOBULAR BREAST CARCINOMAS. Biomedical papers, 149(1), 57-62. doi: 10.5507/bp.2005.005
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rosen PP. Rosens Breast Pathology. Lippincots-Raven Publishers 1997.
    2. Weidner N, Cote R, Suster S, et al. Modern Surgical Pathology. Elsevier Science, 2003. p. 891-2.
    3. Peiro G, Bornstein BA, Connolly JL, Gelman R, Hetelekidis S, Nixon AJ, Recht A, Silver B, Harris JR, Schnitt SJ. (2000) The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59, 49-54. Go to original source... Go to PubMed...
    4. Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ. (2004) Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast 13, 389-96. Go to original source... Go to PubMed...
    5. Jain S, Fisher C, Smith P, Millis RR, Rubens RD. (1993) Patterns of metastatic breast cancer in relation to histological type. Eur J Cancer 29A, 2155-7. Go to original source... Go to PubMed...
    6. Borst MJ, Ingold JA. (1993) Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114, 637-41.
    7. Newman LA, Buzdar AU, Singletary SE, Kuerer HM, Buchholz T, Ames FC, Ross MI, Hunt KK. (2002) A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol 9, 228-34. Go to original source... Go to PubMed...
    8. Arpino G, Bardou VJ, Clark GM, Elledge RM. (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 6, 149-56. Go to original source... Go to PubMed...
    9. Ferlicot S, Vincent-Salomon A, Medioni J, Genin P, Rosty C, Sigal- Zafrani B, Freneaux P, Jouve M, Thiery JP, Sastre-Garau X. (2004) Wide metastatic spreading in infiltrating lobular carcinoma of the breast. Eur J Cancer 40, 336-41. Go to original source... Go to PubMed...
    10. Paumier A, Sagan C, Campion L, Fiche M, Andrieux N, Dravet F, Pioud R, Classe JM. (2003) Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas. J Gynecol Obstet Biol Reprod 32, 529-34.
    11. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM, Gamagami P. (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73, 1673-7. Go to original source... Go to PubMed...
    12. Toikkanen S, Pylkkanen L, Joensuu H. (1997) Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 76, 1234-40. Go to original source... Go to PubMed...
    13. Ruibal A, Nunez MI, del Rio M, Arias J, Martinez MI, Rabadan J, Tejerina A. (1999) Clinical-biological differences between invasive ductal carcinomas and breast lobular carcinomas. Preliminary results. Rev Esp Med Nucl 18, 84-7. Go to PubMed...
    14. Mersin H, Yildirim E, Gulben K, Berberoglu U. (2003) Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol 29, 390-5. Go to original source... Go to PubMed...
    15. Kowalski PJ, Rubin MA, Kleer CG. (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5, R217-22. Go to original source... Go to PubMed...
    16. Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ. (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76, 1131-3. Go to original source... Go to PubMed...
    17. Gupta D, Croitoru CM, Ayala AG, Sahin AA, Middleton LP. (2002) E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast. Ann Diagn Pathol 6, 141-7. Go to original source... Go to PubMed...
    18. Rieger-Christ KM, Pezza JA, Dugan JM, Braasch JW, Hughes KS, Summerhayes IC. (2001) Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol Pathol 54, 91-7. Go to original source... Go to PubMed...
    19. Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H, Gown AM. (2001) E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol 115, 534-42. Go to original source... Go to PubMed...
    20. Lehr HA, Folpe A, Yaziji H, Kommoss F, Gown AM. (2000) Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol 114, 190-6. Go to original source... Go to PubMed...
    21. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ (2001) Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115, 85-98. Go to original source... Go to PubMed...
    22. Goldstein NS. (2002) Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases? Am J Clin Pathol 118, 425-34. Go to original source... Go to PubMed...
    23. Moll R, Mitze M, Frixen UH, Birchmeier W. (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143, 1731-42.
    24. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A. (1993) Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142, 987-93.
    25. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. (1996) Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105, 394-402. Go to original source... Go to PubMed...
    26. Brinck U, Jacobs S, Neuss M, Tory K, Rath W, Kulle B, Fuzesi L. (2004) Diffuse growth pattern affects E-cadherin expression in invasive breast cancer. Anticancer Res 24, 2237-42. Go to PubMed...
    27. Jacobs TW, Pliss N, Kouria G, Schnitt SJ. (2001) Carcinomas In Situ of the Breast With Indeterminate Features: Role of E-Cadherin Staining in Categorization. Am J Surg Pathol 25, 229-236. Go to original source... Go to PubMed...
    28. Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG, Tavassoli FA. (2002) Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 33, 620-7. Go to original source... Go to PubMed...
    29. Rieger-Christ KM, Pezza JA, Dugan JM, Braasch JW, Hughes KS, Summerhayes IC. (2001) Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol Pathol 54, 91-7. Go to original source... Go to PubMed...
    30. Nakopoulou L, Gakiopoulou-Givalou H, Karayiannakis AJ, Giannopoulou I, Keramopoulos A, Davaris P, Pignatelli M. (2002) Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival. Histopathology 40, 536-46. Go to original source... Go to PubMed...
    31. Zschiesche W, Schonborn I, Behrens J, Herrenknecht K, Hartveit F, Lilleng P, Birchmeier W. (1997) Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res 17, 561-7. Go to PubMed...
    32. De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM. (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183, 404- 11. Go to original source... Go to PubMed...
    33. Karayiannakis AJ, Nakopoulou L, Gakiopoulou H, Keramopoulos A, Davaris PS, Pignatelli M. (2001) Expression patterns of betacatenin in in situ and invasive breast cancer. Eur J Surg Oncol 27, 31-6. Go to original source... Go to PubMed...
    34. Han A, Xiong M, Li Z, Liang Y. (2001) E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast. Zhonghua Bing Li Xue Za Zhi 30, 27-30. Go to PubMed...
    35. Heatley M, Maxwell P, Whiteside C, Toner P. (1995). Cytokeratin intermediate filament expression in benign and malignant breast disease. J Clin Pathol 48, 26-32. Go to original source... Go to PubMed...
    36. Tot T. (1990) Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases. Ann Diagn Pathol 3, 350-6. Go to original source... Go to PubMed...
    37. Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W. (2000) Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 37, 232-40. Go to original source... Go to PubMed...
    38. Lacroix-Triki M, Mery E, Voigt JJ, Istier L, Rochaix P. (2003) Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34betaE12 antibody. Virchows Arch 442, 548-54. Go to original source...
    39. Soslow RA, Carlson DL, Horenstein MG, Osborne MP (2000) A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas. Breast Cancer Res and Treat 61, 161-170. Go to original source... Go to PubMed...
    40. Sasano H, Frost AR, Saitoh R, Taniyama Y, Nagura H, Matsunaga G, Takehana K, Kimura M, Silverberg SG. (1997) Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma. Anticancer Res 17, 3685-90.
    41. Naidu R, Wahab NA, Yadav MM, Kutty MK. (2002) Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters. Oncol Rep 9, 409-16. Go to original source... Go to PubMed...
    42. Clezardin P, Frappart L, Clerget M, Pechoux C, Delmas PD. (1993) Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res 53, 1421-30. Go to PubMed...
    43. Serre CM, Clezardin P, Frappart L, Boivin G, Delmas PD. (1995) Distribution of thrombospondin and integrin alpha V in DCIS, invasive ductal and lobular human breast carcinomas. Analysis by electron microscopy. Virchows Arch 427, 365-72. Go to original source... Go to PubMed...
    44. Barbaresch M, Pecciarini L, Cangi MG, Macri E, Rizzo A, Viale G, Doglioni C (2001) p63, a p53 Homologue, Is a Selective Nuclear Marker of Myoepithelial Cells of the Human Breast. Am J Surg Pathol 25, 1054-1060. Go to original source... Go to PubMed...
    45. Chhieng DC, Tabbara SO, Marley EF, Talley LI, Frost AR. (2003) Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma. Breast J 9, 200- 7. Go to original source... Go to PubMed...
    46. Lewis JS, Landers RJ, Underwood JC, Harris AL, Lewis CE. (2000) Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 192, 150-8. Go to original source... Go to PubMed...
    47. Rajesh L, Joshi K, Bhalla V, Dey P, Radotra BD, Nijhawan R. (2004) Correlation between VEGF expression and angiogenesis in breast carcinoma. Anal Quant Cytol Histol 26, 105-8.
    48. Lee AH, Dublin EA, Bobrow LG, Poulsom R. (1998) Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J Pathol 185, 394-401. Go to original source... Go to PubMed...
    49. Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R, Hendrix MJ. (1998) Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 58, 5681-5. Go to PubMed...
    50. Li JJ, Colburn NH, Oberley LW. (1998) Maspin gene expression in tumor suppression induced by overexpressing manganese-containing superoxide dismutase cDNA in human breast cancer cells. Carcinogenesis 19, 833-9. Go to original source... Go to PubMed...
    51. Kim DH, Yoon DS, Dooley WC, Nam ES, Ryu JW, Jung KC, Park HR, Sohn JH, Shin HS, Park YE. (2003) Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancer. Histopathology 42, 37-42. Go to original source... Go to PubMed...
    52. Jiang AL, Zhang JY, Young C, Hu XY, Wang YM, Liu ZF, Hao ML. (2004) Molecular cloning and characterization of human homeobox gene Nkx3.1 promoter. Acta Biochim Biophys Sin (Shanghai) 36, 64-7. Go to original source... Go to PubMed...
    53. Tanaka M, Lyons GE, Izumo S. (1999) Expression of the Nkx3.1 homobox gene during pre and postnatal development. Mech Dev 85, 179-82. Go to original source... Go to PubMed...
    54. Prescott JL, Blok L, Tindall DJ. (1998) Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate 35, 71-80. Go to original source... Go to PubMed...
    55. Gelmann EP, Bowen C, Bubendorf L. (2003) Expression of NKX3.1 in normal and malignant tissues. Prostate 55, 111-7. Go to original source... Go to PubMed...
    56. Bentz JS, Yassa N, Clayton F. (1998) Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod Pathol 11, 814-22. Go to PubMed...
    57. Weidner N, Semple JP. (1992) Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 23, 1167-71. Go to original source... Go to PubMed...
    58. Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ. (2004) Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 24, 1650-6. Go to original source... Go to PubMed...
    59. Radhi JM. (2000) Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR. Histopathology 36, 156-60. Go to original source... Go to PubMed...
    60. Wahed A, Connelly J, Reese T. (2002) E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Ann Diagn Pathol 6, 349-51. Go to original source... Go to PubMed...
    61. Frolik D, Caduff R, Varga Z. (2001) Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Histopathology 39, 503-13. Go to original source... Go to PubMed...
    62. Sneige N, Wang J, Baker B, Krishnamurthy S, Middleton L. (2002) Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: A Report of 24 Cases. Mod Pathol 15, 1044-1050. Go to original source... Go to PubMed...

    Return to the content